Literature DB >> 20091458

Progress in primary aldosteronism: present challenges and perspectives.

C E Gomez-Sanchez1, G P Rossi, F Fallo, M Mannelli.   

Abstract

Primary Aldosteronism (PA) is a disorder of the adrenal zona glomerulosa (ZG) in which aldosterone secretion is increased and is relatively autonomous of normal regulatory mechanisms. A recent conference in Munich organized by Prof. Reincke addressed advances and challenges related to the screening, diagnosis, and identification of uni- and bilateral involvement of the diseased adrenal of PA. Some infrequently addressed issues are described herein. We postulate that most cases of PA are due to the activation by unknown mechanisms of subset of cells resulting in the formation of a multiple foci or nodules of hyperactive zona glomerulosa cells. This implies that one or several yet unidentified stimuli can drive aldosterone overproduction, as well as the proliferation of aldosterone-producing cells. Current diagnostic procedures allow to determine whether inappropriate aldosterone production is driven by one or both adrenal glands and thus to establish optimal treatment. Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091458      PMCID: PMC4823770          DOI: 10.1055/s-0029-1243619

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  99 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  A study of the adrenal status in hypertension.

Authors:  A H SHAMMA; J W GODDARD; S C SOMMERS
Journal:  J Chronic Dis       Date:  1958-11

3.  Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in man.

Authors:  W Oelkers; M Schöneshöfer; G Schultze; J J Brown; R Fraser; J J Morton; A F Lever; J I Robertson
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

4.  Left ventricular systolic function in primary aldosteronism and hypertension.

Authors:  G P Rossi; A Sacchetto; E Pavan; R Scognamiglio; M Pietra; A C Pessina
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

5.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

6.  Comparison of sequential versus simultaneous methods of adrenal venous sampling.

Authors:  Caitlin E Carr; Constantin Cope; Debbie L Cohen; Douglas L Fraker; Scott O Trerotola
Journal:  J Vasc Interv Radiol       Date:  2004-11       Impact factor: 3.464

7.  Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma.

Authors:  E Davies; A Bonnardeaux; P F Plouin; P Corvol; E Clauser
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

8.  Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway.

Authors:  Neoklis A Georgopoulos; Gerasimos P Sykiotis; Argyro Sgourou; Adamantia Papachatzopoulou; Kostas B Markou; Venetsana Kyriazopoulou; Athanasios G Papavassiliou; Apostolos G Vagenakis
Journal:  Eur J Endocrinol       Date:  2003-10       Impact factor: 6.664

9.  Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.

Authors:  R D Collins; M H Weinberger; A J Dowdy; G W Nokes; C M Gonzales; J A Luetscher
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

10.  The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.

Authors:  M Wisgerhof; R D Brown; M J Hogan; P C Carpenter; A J Edis
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

View more
  14 in total

Review 1.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

2.  Comparison of aldosterone production among human adrenocortical cell lines.

Authors:  T Wang; J G Rowland; J Parmar; M Nesterova; T Seki; W E Rainey
Journal:  Horm Metab Res       Date:  2012-01-20       Impact factor: 2.936

3.  Aldosterone-producing adenomas: mining for genes.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Hypertension       Date:  2010-04-12       Impact factor: 10.190

Review 4.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 5.  Central regulation of blood pressure by the mineralocorticoid receptor.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 6.  Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?

Authors:  Elise P Gomez-Sanchez
Journal:  Trends Endocrinol Metab       Date:  2011-03-21       Impact factor: 12.015

7.  Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new.

Authors:  Cristiana Catena; Gianluca Colussi; Gabriele Brosolo; Lorenzo Iogna-Prat; Leonardo A Sechi
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

Review 8.  The ubiquitous mineralocorticoid receptor: clinical implications.

Authors:  Urseline A Hawkins; Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 9.  Immunohistochemistry of the adrenal in primary aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-06       Impact factor: 3.243

10.  Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.

Authors:  Lucie S Meyer; Xiao Wang; Eva Sušnik; Jacopo Burrello; Alessio Burrello; Isabella Castellano; Graeme Eisenhofer; Francesco Fallo; Gregory A Kline; Thomas Knösel; Tomaz Kocjan; Jacques W M Lenders; Paolo Mulatero; Mitsuhide Naruse; Tetsuo Nishikawa; Mirko Peitzsch; Lars C Rump; Felix Beuschlein; Stefanie Hahner; Celso E Gomez-Sanchez; Martin Reincke; Tracy Ann Williams
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.